Global (United States, European Union and China) Lung Cancer Diagnostic Tests Market Research Report 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Lung Cancer Diagnostic Tests Revenue
• 1.4 Market by Type
  • 1.4.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Immunoassays
  • 1.4.3 Flow Cytometry
  • 1.4.4 Rapid Tests
  • 1.4.5 Molecular Assays
  • 1.4.6 Tissue Arrays
  • 1.4.7 Circulating Tumor Cells
  • 1.4.8 Pharmacodiagnostics
  • 1.4.9 Biomarkers
  • 1.4.10 Other Diagnostics Methods
• 1.5 Market by Application
  • 1.5.1 Global Lung Cancer Diagnostic Tests Market Share by Application: 2020 VS 2026
  • 1.5.2 Precision Medicine
  • 1.5.3 Personalized Medicine
  • 1.5.4 Cancer Monitoring
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Lung Cancer Diagnostic Tests Market Perspective (2015-2026)
• 2.2 Global Lung Cancer Diagnostic Tests Growth Trends by Regions
  • 2.2.1 Lung Cancer Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Lung Cancer Diagnostic Tests Historic Market Share by Regions (2015-2020)
  • 2.2.3 Lung Cancer Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Lung Cancer Diagnostic Tests Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Lung Cancer Diagnostic Tests Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Lung Cancer Diagnostic Tests Players by Market Size
  • 3.1.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue (2015-2020)
  • 3.1.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Lung Cancer Diagnostic Tests Market Concentration Ratio
  • 3.2.1 Global Lung Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostic Tests Revenue in 2019
• 3.3 Lung Cancer Diagnostic Tests Key Players Head office and Area Served
• 3.4 Key Players Lung Cancer Diagnostic Tests Product Solution and Service
• 3.5 Date of Enter into Lung Cancer Diagnostic Tests Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Type (2015-2020)
• 4.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
• 5.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Lung Cancer Diagnostic Tests Market Size (2015-2020)
• 6.2 Lung Cancer Diagnostic Tests Key Players in North America (2019-2020)
• 6.3 North America Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 6.4 North America Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Lung Cancer Diagnostic Tests Market Size (2015-2020)
• 7.2 Lung Cancer Diagnostic Tests Key Players in Europe (2019-2020)
• 7.3 Europe Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 7.4 Europe Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)

8 China

• 8.1 China Lung Cancer Diagnostic Tests Market Size (2015-2020)
• 8.2 Lung Cancer Diagnostic Tests Key Players in China (2019-2020)
• 8.3 China Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 8.4 China Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Lung Cancer Diagnostic Tests Market Size (2015-2020)
• 9.2 Lung Cancer Diagnostic Tests Key Players in Japan (2019-2020)
• 9.3 Japan Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 9.4 Japan Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Lung Cancer Diagnostic Tests Market Size (2015-2020)
• 10.2 Lung Cancer Diagnostic Tests Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 10.4 Southeast Asia Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)

11 India

• 11.1 India Lung Cancer Diagnostic Tests Market Size (2015-2020)
• 11.2 Lung Cancer Diagnostic Tests Key Players in India (2019-2020)
• 11.3 India Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 11.4 India Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Lung Cancer Diagnostic Tests Market Size (2015-2020)
• 12.2 Lung Cancer Diagnostic Tests Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 12.4 Central & South America Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Advpharma Inc
  • 13.1.1 Advpharma Inc Company Details
  • 13.1.2 Advpharma Inc Business Overview
  • 13.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Introduction
  • 13.1.4 Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2015-2020))
  • 13.1.5 Advpharma Inc Recent Development
• 13.2 AIT Austrian Institute of Technology GmbH
  • 13.2.1 AIT Austrian Institute of Technology GmbH Company Details
  • 13.2.2 AIT Austrian Institute of Technology GmbH Business Overview
  • 13.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Introduction
  • 13.2.4 AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.2.5 AIT Austrian Institute of Technology GmbH Recent Development
• 13.3 Courtagen Life Sciences Inc
  • 13.3.1 Courtagen Life Sciences Inc Company Details
  • 13.3.2 Courtagen Life Sciences Inc Business Overview
  • 13.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Introduction
  • 13.3.4 Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.3.5 Courtagen Life Sciences Inc Recent Development
• 13.4 DiagnoCure Inc. (Inactive)
  • 13.4.1 DiagnoCure Inc. (Inactive) Company Details
  • 13.4.2 DiagnoCure Inc. (Inactive) Business Overview
  • 13.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Introduction
  • 13.4.4 DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.4.5 DiagnoCure Inc. (Inactive) Recent Development
• 13.5 BioMark Diagnostics Inc.
  • 13.5.1 BioMark Diagnostics Inc. Company Details
  • 13.5.2 BioMark Diagnostics Inc. Business Overview
  • 13.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Introduction
  • 13.5.4 BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.5.5 BioMark Diagnostics Inc. Recent Development
• 13.6 BioMarker Strategies LLC
  • 13.6.1 BioMarker Strategies LLC Company Details
  • 13.6.2 BioMarker Strategies LLC Business Overview
  • 13.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Introduction
  • 13.6.4 BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.6.5 BioMarker Strategies LLC Recent Development
• 13.7 Emory University
  • 13.7.1 Emory University Company Details
  • 13.7.2 Emory University Business Overview
  • 13.7.3 Emory University Lung Cancer Diagnostic Tests Introduction
  • 13.7.4 Emory University Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.7.5 Emory University Recent Development
• 13.8 Epigenomics AG
  • 13.8.1 Epigenomics AG Company Details
  • 13.8.2 Epigenomics AG Business Overview
  • 13.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Introduction
  • 13.8.4 Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.8.5 Epigenomics AG Recent Development
• 13.9 GlycoZym
  • 13.9.1 GlycoZym Company Details
  • 13.9.2 GlycoZym Business Overview
  • 13.9.3 GlycoZym Lung Cancer Diagnostic Tests Introduction
  • 13.9.4 GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.9.5 GlycoZym Recent Development
• 13.10 HalioDx SAS
  • 13.10.1 HalioDx SAS Company Details
  • 13.10.2 HalioDx SAS Business Overview
  • 13.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Introduction
  • 13.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 13.10.5 HalioDx SAS Recent Development
• 13.11 Louisville Bioscience, Inc.
  • 10.11.1 Louisville Bioscience, Inc. Company Details
  • 10.11.2 Louisville Bioscience, Inc. Business Overview
  • 10.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Introduction
  • 10.11.4 Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 10.11.5 Louisville Bioscience, Inc. Recent Development
• 13.12 Mayo Clinic US
  • 10.12.1 Mayo Clinic US Company Details
  • 10.12.2 Mayo Clinic US Business Overview
  • 10.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Introduction
  • 10.12.4 Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
  • 10.12.5 Mayo Clinic US Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer